Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucilla Parnetti

Showing results (161-170 of 283) with videos related to

Pageof 29
Sort By:
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
Emerging topics and practical aspects for an appropriate use of amyloid PET in the current Italian contextFlavio Nobili, Annachiara Cagnin, Maria L Calcagni, et al.
Neurobiology of Aging|October 15, 2018
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathologyCinzia Costa, Michele Romoli, Claudio Liguori, et al.
Frontiers in Neuroscience|April 19, 2021
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological DisordersGiovanni Bellomo, Antonio Indaco, Davide Chiasserini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assayGiovanni Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
ACR Open Rheumatology|June 21, 2026
Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I AntibodiesMarta Di Berardino, Pasquale Nigro, Lorenza Bruno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2025
Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementiasLorenzo Barba, Giovanni Bellomo, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|July 23, 2016
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical RoutineDavide Chiasserini, Leonardo Biscetti, Lucia Farotti, et al.
Alzheimer'S Research & Therapy|July 15, 2023
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuumSilvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsyBarbara Borroni, Matteo Malinverno, Fabrizio Gardoni, et al.
The Lancet Regional Health. Europe|October 24, 2024
Fluid biomarkers in multiple sclerosis: from current to future applicationsMassimiliano Di Filippo, Lorenzo Gaetani, Diego Centonze, et al.
Pageof 29

Showing results (161-170 of 283) with videos related to

Sort By:
Pageof 29
The Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|April 27, 2018
Emerging topics and practical aspects for an appropriate use of amyloid PET in the current Italian contextFlavio Nobili, Annachiara Cagnin, Maria L Calcagni, et al.
Neurobiology of Aging|October 15, 2018
Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathologyCinzia Costa, Michele Romoli, Claudio Liguori, et al.
Frontiers in Neuroscience|April 19, 2021
Machine Learning Driven Profiling of Cerebrospinal Fluid Core Biomarkers in Alzheimer's Disease and Other Neurological DisordersGiovanni Bellomo, Antonio Indaco, Davide Chiasserini, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|February 7, 2024
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assayGiovanni Bellomo, Andrea Toja, Federico Paolini Paoletti, et al.
ACR Open Rheumatology|June 21, 2026
Italian Olfactory Identification Test in Systemic Lupus Erythematosus: Association of Olfactory Impairment With Chronic Damage and Anti-β<sub>2</sub>-Glycoprotein I AntibodiesMarta Di Berardino, Pasquale Nigro, Lorenza Bruno, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|June 26, 2025
Serum level changes of the synaptic marker beta-synuclein in Alzheimer's disease continuum and other dementiasLorenzo Barba, Giovanni Bellomo, Daniel Alcolea, et al.
Journal of Alzheimer'S Disease : JAD|July 23, 2016
Performance Evaluation of an Automated ELISA System for Alzheimer's Disease Detection in Clinical RoutineDavide Chiasserini, Leonardo Biscetti, Lucia Farotti, et al.
Alzheimer'S Research & Therapy|July 15, 2023
Potential diagnostic value of CSF metabolism-related proteins across the Alzheimer's disease continuumSilvia Paciotti, Anna Lidia Wojdała, Giovanni Bellomo, et al.
Journal of Alzheimer'S Disease : JAD|September 18, 2010
A combination of CSF tau ratio and midsaggital midbrain-to-pons atrophy for the early diagnosis of progressive supranuclear palsyBarbara Borroni, Matteo Malinverno, Fabrizio Gardoni, et al.
The Lancet Regional Health. Europe|October 24, 2024
Fluid biomarkers in multiple sclerosis: from current to future applicationsMassimiliano Di Filippo, Lorenzo Gaetani, Diego Centonze, et al.
Pageof 29